Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease

Journal of Neurochemistry

Volumn 120, Issue SUPPL. 1, 2012, Pages 140-148

  Ma, Tao ^a   Klann, Eric ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

amyloid ; glycogen synthase kinase 3; long term potentiation; mammalian target of rapamycin; NMDA receptors; reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RAPAMYCIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEMENTIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEARNING; LONG TERM POTENTIATION; MEMORY DISORDER; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION DISORDERS; HUMANS; MEMORY DISORDERS; NEURONAL PLASTICITY; SYNAPSES; SYNAPTIC TRANSMISSION;

MAMMALIA;

EID: 84655160769     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07506.x     Document Type: Review

References (126)

1. An W.-L., Cowburn R. F., Li L., Braak H., Alafuzoff I., Iqbal K., Iqbal I.-G., Winblad B., and, Pei J.-J., (2003) Up-regulation of phosphorylated/ activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am. J. Pathol. 163, 591-607. (Pubitemid 36909421)
2. Antion M. D., Merhav M., Hoeffer C. A., Reis G., Kozma S. C., Thomas G., Schuman E. M., Rosenblum K., and, Klann E., (2008) Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity. Learn. Mem. 15, 29-38. (Pubitemid 351171603)
3. Artola A., and, Singer W., (1993) Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation. Trends Neurosci. 16, 480-487. (Pubitemid 23313527)
4. Ashe K. H., (2001) Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8, 301-308. (Pubitemid 34037573)
5. Asuni A. A., Hooper C., Reynolds C. H., Lovestone S., Anderton B. H., and, Killick R., (2006) GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt. Eur. J. Neurosci. 24, 3387-3392. (Pubitemid 44952605)
6. Averous J., and, Proud C. G., (2006) When translation meets transformation: the mTOR story. Oncogene 25, 6423-6435. (Pubitemid 44582286)
7. Balaban R. S., Nemoto S., and, Finkel T., (2005) Mitochondria, oxidants, and aging. Cell 120, 483-495. (Pubitemid 40269763)
8. Balaraman Y., Limaye A. R., Levey A. I., and, Srinivasan S., (2006) Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance. Cell. Mol. Life Sci. 63, 1226-1235. (Pubitemid 43939009)
9. Banko J. L., Poulin F., Hou L., DeMaria C. T., Sonenberg N., and, Klann E., (2005) The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J. Neurosci. 25 (42), 9581-9590. (Pubitemid 41510899)
10. Banko J. L., Merhav M., Stern E., Sonenberg N., Rosenblum K., and, Klann E., (2007) Behavioral alterations in mice lacking the translation repressor 4E-BP2. Neurobiol. Learn. Mem. 87, 248-256. (Pubitemid 46038953)
11. Bhaskar P. T., and, Hay N., (2007) The two TORCs and Akt. Dev. Cell 12, 487-502. (Pubitemid 46523652)
12. Bindokas V. P., Jordan J., Lee C. C., and, Miller R. J., (1996) Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16, 1324-1336. (Pubitemid 26145913)
13. Bliss T. V., and, Collingridge G. L., (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39. (Pubitemid 23020772)
14. Bliss T. V., and, Lomo T., (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232, 331-356.
15. Blundell J., Kouser M., and, Powell C. M., (2008) Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation. Neurobiol. Learn. Mem. 90, 28-35.
16. Caccamo A., Majumder S., Richardson A., Strong R., and, Oddo S., (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107-13120.
17. Chapman P. F., Falinska A. M., Knevett S. G., and, Ramsay M. F., (2001) Genes, models and Alzheimer's disease. Trends Genet. 17, 254-261. (Pubitemid 32378748)
18. Cheng L., Yin W.-J., Zhang J.-F., and, Qi J.-S., (2009) Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse 63, 206-214.
19. Cirrito J. R., Yamada K. A., Finn M. B., Sloviter R. S., Bales K. R., May P. C., Schoepp D. D., Paul S. M., Mennerick S., and, Holtzman D. M., (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922. (Pubitemid 41814696)
20. Cirrito J. R., Kang J.-E., Lee J., Stewart F. R., Verges D. K., Silverio L. M., Bu G., Mennerick S., and, Holtzman D. M., (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58, 42-51. (Pubitemid 351467029)
21. Cissé M., Halabisky B., Harris J., et al. (2011) Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469, 47-52.
22. Cleary J., Hittner J. M., Semotuk M., Mantyh P., and, O'Hare E., (1995) Beta-amyloid(1-40) effects on behavior and memory. Brain Res. 682, 69-74.
23. Cleary J. P., Walsh D. M., Hofmeister J. J., Shankar G. M., Kuskowski M. A., Selkoe D. J., and, Ashe K. H., (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84. (Pubitemid 41236735)
24. Cohen E., Paulsson J. F., Blinder P., et al. (2009) Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139, 1157-1169.
25. De Felice F., Vieira M. N. N., Bomfim T. R., Decker H., Velasco P. T., Lambert M. P., Viola K. L., Zhao W.-Q., Ferreira S. T., and, Klein W. L., (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl. Acad. Sci. USA 106, 1971-1976.
26. Doble B. W., Patel S., Wood G. A., Kockeritz L. K., and, Woodgett J. R., (2007) Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12, 957-971. (Pubitemid 46805920)
27. Dumont M., Wille E., Stack C., Calingasan N. Y., Beal M. F., and, Lin M. T., (2009) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J. 23, 2459-2466.
28. Dyer M., Renner W., and, Bachmann M., (2006) A second vaccine revolution for the new epidemics of the 21st century. Drug Discov. Today 11, 1028-1033. (Pubitemid 44572882)
29. Embi N., Rylatt D., and, Cohen P., (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519-527.
30. Esch F., Keim P., Beattie E., Blacher R., Culwell A., Oltersdorf T., McClure D., and, Ward P., (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124.
31. Esposito L., Raber J., Kekonius L., Yan F., Yu G.-Q., Bien-Ly N., Puoliväli J., Scearce-Levie K., Masliah E., and, Mucke L., (2006) Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 26, 5167-5179. (Pubitemid 44315298)
32. Fiorentini A., Rosi M. C., Grossi C., Luccarini I., and, Casamenti F., (2010) Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice. PLoS ONE 5, e14382.
33. Force T., and, Woodgett J. R., (2009) Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J. Biol. Chem. 284, 9643-9647.
34. Frame S., and, Cohen P., (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1-16. (Pubitemid 32939202)
35. Gafford G. M., Parsons R. G., and, Helmstetter F. J., (2011) Consolidation and reconsolidation of contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal hippocampus. Neuroscience 182, 98-104.
36. Garcia-Osta A., and, Alberini C. M., (2009) Amyloid beta mediates memory formation. Learn. Mem. 16, 267-272.
37. Gladding C. M., and, Raymond L. A., (2011) Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Mol. Cell. Neurosci. [Epub ahead of print].
38. Glenner M. D. G. G., and, Wong C. W., (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (3), 885-890. (Pubitemid 14104991)
39. Gouras G. K., Almeida C. G., and, Takahashi R. H., (2005) Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging 26, 1235-1244. (Pubitemid 41338539)
40. Gouras G. K., Tampellini D., Takahashi R. H., and, Capetillo-Zarate E., (2010) Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol. 119, 523-541.
41. Haass C., and, Selkoe D. J., (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112. (Pubitemid 46432529)
42. Hardingham G. E., and, Bading H., (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 26, 81-89. (Pubitemid 36110542)
43. Hardingham G. E., Fukunaga Y., and, Bading H., (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405-414. (Pubitemid 34454245)
44. Harrison D. E., Strong R., Sharp Z. D., et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395.
45. Hay N., and, Sonenberg N., (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945. (Pubitemid 39071573)
46. Hoeffer C. A., and, Klann E., (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75.
47. Hoeffer C. A., Cowansage K. K., Arnold E. C., et al. (2011) Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidation. Proc. Natl. Acad. Sci. USA 108, 3383-3388.
48. Hoeflich K. P., Luo J., Rubie E. A., Tsao M.-S., Jin O., and, Woodgett J. R., (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86-90. (Pubitemid 30460216)
49. Hooper C., Killick R., and, Lovestone S., (2008) The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433-1439. (Pubitemid 351316776)
50. Hu D., Serrano F., Oury T. D., and, Klann E., (2006) Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 26, 3933-3941. (Pubitemid 44315413)
51. Hu D., Cao P., Thiels E., Chu C. T., Wu G.-y., Oury T. D., and, Klann E., (2007) Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiol. Learn. Mem. 87, 372-384. (Pubitemid 46137009)
52. Huang J., and, Manning B., (2009) A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem. Soc. Trans. 37, 217-222.
53. Huddleston A. T., Tang W., Takeshima H., Hamilton S. L., and, Klann E., (2008) Superoxide-induced potentiation in the hippocampus requires activation of ryanodine receptor type 3 and ERK. J. Neurophysiol. 99, 1565-1571. (Pubitemid 351413732)
54. Hur E.-M., and, Zhou F.-Q., (2010) GSK3 signalling in neural development. Nat. Rev. Neurosci. 11, 539-551.
55. Jacobsen J. S., Wu C.-C., Redwine J. M., et al. (2006) Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103, 5161-5166.
56. Janus C., and, Westaway D., (2001) Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 73, 873-886. (Pubitemid 32885575)
57. Jo J., Whitcomb D. J., Olsen K. M., et al. (2011) Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nat. Neurosci. 14, 545-547.
58. Jope R. S., and, Johnson G. V. W., (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102. (Pubitemid 38186580)
59. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., and, Malinow R., (2003) APP processing and synaptic function. Neuron 37, 925-937. (Pubitemid 36398299)
60. Kamsler A., and, Segal M., (2003) Paradoxical actions of hydrogen peroxide on long-term potentiation in transgenic superoxide dismutase-1 mice. J. Neurosci. 23, 10359-10367. (Pubitemid 37444613)
61. Kandel E. R., (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030-1038. (Pubitemid 33041851)
62. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K.-H., Multhaup G., Beyreuther K., and, Muller-Hill B., (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. (Pubitemid 17054046)
63. Kim J.-H., Anwyl R., Suh Y.-H., Djamgoz M. B. A., and, Rowan M. J., (2001) Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21, 1327-1333. (Pubitemid 32128777)
64. Kishida K. T., Pao M., Holland S. M., and, Klann E., (2005) NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J. Neurochem. 94, 299-306. (Pubitemid 40995246)
65. Klann E., (1998) Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. J. Neurophysiol. 80, 452-457. (Pubitemid 28326275)
66. Klann E., Roberson E. D., Knapp L. T., and, Sweatt J. D., (1998) A role for superoxide in protein kinase C activation and induction of long-term potentiation. J. Biol. Chem. 273, 4516-4522. (Pubitemid 28103192)
67. Knapp L. T., and, Klann E., (2002) Potentiation of hippocampal synaptic transmission by superoxide requires the oxidative activation of protein kinase C. J. Neurosci. 22, 674-683. (Pubitemid 34141748)
68. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M. C., Gil R., Pradier L., and, Hugon J., (2005) mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J. Neurochem. 94, 215-225. (Pubitemid 40911407)
69. Lafay-Chebassier C., Pérault-Pochat M. C., Page G., Bilan A. R., Damjanac M., Pain S., Houeto J.-L., Gil R., and, Hugon J., (2006) The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide. J. Neurosci. Res. 84, 1323-1334. (Pubitemid 44654455)
70. LaFerla F. M., Green K. N., and, Oddo S., (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509.
71. Lau C. G., and, Zukin R. S., (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8, 413-426. (Pubitemid 46789232)
72. Lau C. G., Takeuchi K., Rodenas-Ruano A., Takayasu Y., Murphy J., Bennett M. V. L., and, Zukin R. S., (2009) Regulation of NMDA receptor Ca2 + signalling and synaptic plasticity. Biochem. Soc. Trans. 37, 1369-1374.
73. Lee H.-K., Kumar P., Fu Q., Rosen K. M., and, Querfurth H. W., (2009) The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol. Biol. Cell 20, 1533-1544.
74. Lesné S., Koh M. T., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M., and, Ashe K. H., (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
75. Li F., Calingasan N. Y., Yu F., et al. (2004) Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89, 1308-1312. (Pubitemid 38715849)
76. Li S., Hong S., Shepardson N. E., Walsh D. M., Shankar G. M., and, Selkoe D., (2009) Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801.
77. Li S., Jin M., Koeglsperger T., Shepardson N. E., Shankar G. M., and, Selkoe D. J., (2011) Soluble A{beta} Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors. J. Neurosci. 31, 6627-6638.
78. Lin M. T., and, Beal M. F., (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. (Pubitemid 44622683)
79. Ma T., Hoeffer C. A., Capetillo-Zarate E., Yu F., Wong H., Lin M. T., Tampellini D., Klann E., Blitzer R. D., and, Gouras G. K., (2010) Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS ONE 5, e12845.
80. Ma T., Hoeffer C. A., Wong H., Massaad C. A., Zhou P., Iadecola C., Murphy M. P., Pautler R. G., and, Klann E., (2011) Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J. Neurosci. 31, 5589-5595.
81. MacAulay K., Doble B. W., Patel S., Hansotia T., Sinclair E. M., Drucker D. J., Nagy A., and, Woodget J. R., (2007) Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab. 6, 329-337. (Pubitemid 47450185)
82. Magrané J., Rosen K. M., Smith R. C., Walsh K., Gouras G. K., and, Querfurth H. W., (2005) Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J. Neurosci. 25 (47), 10960-10969. (Pubitemid 41692626)
83. Malenka R. C., (2003) The long-term potential of LTP. Nat. Rev. Neurosci. 4, 923-926. (Pubitemid 37351431)
84. Malenka R. C., and, Bear M. F., (2004) LTP and LTD: an embarrassment of riches. Neuron 44, 5-21. (Pubitemid 39348827)
85. Malenka R. C., and, Nicoll R. A., (1999) Long-term potentiation-a decade of progress? Science 285, 1870-1874.
86. Massaad C. A., and, Klann E., (2011) Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid. Redox Signal. 14, 2013-2054.
87. Massaad C. A., Washington T. M., Pautler R. G., and, Klann E., (2009) Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 106, 13576-13581.
88. Masters C. L., Simms G., Weinman N. A., Multhaup G., Mcdonald B. L., and, Beyreuther K., (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249. (Pubitemid 15053619)
89. McDonald M., Dahl E., Overmier J., Mantyh P., and, Cleary J., (1994) Effects of an exogenous beta-amyloid peptide on retention for spatial learning. Behav. Neural Biol. 62, 60-67.
90. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., and, LaFerla F. M., (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. (Pubitemid 36937044)
91. Parsons R. G., Gafford G. M., and, Helmstetter F. J., (2006) Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. J. Neurosci. 26, 12977-12983. (Pubitemid 44954616)
92. Peineau S., Taghibiglou C., Bradley C., et al. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53, 703-717. (Pubitemid 46283369)
93. Peineau S., Bradley C., Taghibiglou C., Doherty A., Bortolotto Z. A., Wang Y. T., and, Collingridge G. L., (2008) The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol. 153, S428-S437. (Pubitemid 351341021)
94. Phiel C. J., Wilson C. A., Lee V. M.-Y., and, Klein P. S., (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423, 435-439. (Pubitemid 36626994)
95. Praticò D., (2008) Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol. Sci. 29, 609-615.
96. Puzzo D., Privitera L., Leznik E., Fà M., Staniszewski A., Palmeri A., and, Arancio O., (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 14537-14545.
97. Querfurth H. W., and, LaFerla F. M., (2010) Alzheimer's disease. N. Engl. J. Med. 362, 329-344.
98. Raymond C. R., Ireland D. R., and, Abraham W. C., (2003) NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus. Brain Res. 968, 263-272. (Pubitemid 36349684)
99. Rebola N., Srikumar B. N., and, Mulle C., (2010) Activity-dependent synaptic plasticity of NMDA receptors. J. Physiol. 588, 93-99.
100. Reger M., Watson G., Green P., et al. (2008) Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70, 440-448.
101. Reiling J. H., and, Sabatini D. M., (2006) Stress and mTORture signaling. Oncogene 25, 6373-6383. (Pubitemid 44582282)
102. Richter J. D., and, Klann E., (2009) Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev. 23, 1-11.
103. Rowan M. J., Klyubin I., Wang Q., and, Anwyl R., (2005) Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochem. Soc. Trans. 33, 563-567. (Pubitemid 41160810)
104. Selkoe D. J., (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453.
105. Selkoe D. J., (2004) Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140, 627-638.
106. Selman C., Tullet J. M. A., Wieser D., et al. (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326, 140-144.
107. Shankar G. M., Bloodgood B. L., Townsend M., Walsh D. M., Selkoe D. J., and, Sabatini B. L., (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866-2875. (Pubitemid 46438992)
108. Shankar G. M., Li S., Mehta T. H., et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842.
109. Smith M. A., Zhu X., Tabaton M., et al. (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 19, 363-372.
110. Snyder E. M., Nong Y., Almeida C. G., et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051-1058. (Pubitemid 41061516)
111. Spilman P., Podlutskaya N., Hart M. J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., and, Galvan V., (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 5, e9979.
112. Stanton P. K., (1996) LTD, LTP, and the sliding threshold for long-term synaptic plasticity. Hippocampus 6, 35-42. (Pubitemid 26153050)
113. Stéphan A., Laroche S., and, Davis S., (2001) Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21, 5703-5714. (Pubitemid 32692169)
114. Stoica L., Zhu P. J., Huang W., Zhou H., Kozma S. C., and, Costa-Mattioli M., (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl. Acad. Sci. USA 108, 3791-3796.
115. Su Y., Ryder J., Li B., et al. (2004) Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry 43, 6899-6908. (Pubitemid 38720508)
116. Sun X., Sato S., Murayama O., Murayama M., Park J., Yamaguchi H., and, Takashima A., (2002) Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100. Neurosci. Lett. 321, 61-64. (Pubitemid 34185499)
117. Tampellini D., Rahman N., Gallo E. F., et al. (2009) Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J. Neurosci. 29, 9704-9713.
118. Tampellini D., Capetillo-Zarate E., Dumont M., Huang Z., Yu F., Lin M. T., and, Gouras G. K., (2010) Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J. Neurosci. 30, 14299-14304.
119. Terwel D., Muyllaert D., Dewachter I., Borghgraef P., Croes S., Devijver H., and, Leuven F. V., (2008) Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol. 172, 786-798. (Pubitemid 351354550)
120. Townsend M., Mehta T., and, Selkoe D. J., (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem. 282, 33305-33312. (Pubitemid 350159548)
121. Wang H.-W., Pasternak J. F., Kuo H., et al. (2002) Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924, 133-140. (Pubitemid 34102301)
122. Woodgett J. R., (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438.
123. Xia P., Huei-sheng Chen V., Zhang D., and, Lipton S. A., (2010) Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J. Neurosci. 30, 11246-11250.
124. Yang Q., and, Guan K.-L., (2007) Expanding mTOR signaling. Cell Res. 17, 666-681. (Pubitemid 47255937)
125. Zahs K. R., and, Ashe K. H., (2010) 'Too much good news'- are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? Trends Neurosci. 33, 381-389.
126. Zhu X., Su B., Wang X., Smith M. A., and, Perry G., (2007) Causes of oxidative stress in Alzheimer disease. Cell. Mol. Life Sci. 64, 2202-2210. (Pubitemid 47347959)